Table 1.
Nutraceutical | Main Dietary Sources | Probable Antidepressant Effects | Clinical Evidence | Side Effects or Limitations | References |
---|---|---|---|---|---|
Omega 3 | Oily fish, nuts, seeds | Targeting of lipid rafts and G coupled protein receptors; Influencing neurotransmission; Stimulation of myelin proteins; Improved cognitive functioning and neuronal cytoarchitecture; Positive influence in the endocannabinoid system and BDNF activity; Anti-inflammatory effects | Major clinical efficacy appears at combined doses of EPA (>60%) + DHA | Long-term results; More effective in patients with mild to moderate depressive symptoms | [81,82,83,99,100] |
Vitamin D | Oily fish, dairy products, eggs, seafood | Immune and microbial homeostasis; Serotonin synthesis; Circadian clock; Increased BDNF activity | Vitamin D3 at a dose of 50,000 IU/week show possible antidepressant effects also improving sleep quality vitamin D deficiency as a possible risk factor for late-life depression |
Further clinical evidence is warranted | [114,115,116,118,120] |
SAMe | Endogenously synthesized or supplements | Influence monoamine synthesis and activity; Improved methylation status and BDNF activity; Anti-inflammatory effects and targeting microbiota–gut–brain axis. | Combination of SAMe with standard antidepressants but not alone have demonstrated the safety, efficacy and tolerability of this component. One study also shows improved action when combined with probiotics | Possible sex-dependent effects; | [129,130,131,132,133,134,135,136,137,138] |
Methylfolate | Endogenously synthesized or supplements | Improved monoamine synthesis and activity; Anti-inflammatory effects; Restoring SAMe levels in the organism | More benefits than supplementation with folate are obtained; 15 mg of methylfolate but not 7.5 exert possible antidepressant effects with standard therapies; High BMI, inflammatory mediators and leptin levels appears to act as predictive; Pregnant women or individuals with reduced MTHFR activity may be potential candidates for this nutraceutical |
One case report study described a relapse of psoriasis in a 61 years old woman after 15 mg/day of methylfolate; Further evidence is warranted | [149,150,151,152,153,154] |
Prebiotics | Fruits, vegetables, whole grains, legumes | Growing of beneficial bacteria | Some studies have found mild efficacy of prebiotic in MDD, but more prominently with probiotics | Prebiotics alone may not have any positive action for patients with MDD | [195,196,197] |
Probiotics | Yogurt, kefir, kombucha, tempeh, miso | Growing of beneficial bacteria in the gut | Certain probiotic species alone or in combination improves clinical parameters in patients <65 years | Elderly people appear to be less sensitive to probiotics | [190,191,192,193,194] |
Carnitine | Fish, meats, dairy products | Anti-inflammatory effects; Antioxidant; Improved metabolic profile; Cognitive enhancement; Neuroplastic effects; Increased BDNF activity; Probable effects in neurotransmitter functioning | 2 to 6 g per day of creatine supplementation appears to be well-tolerated and effective in patients with MDD | In patients with bipolar depression, it may increase the risk of suffering from hypomania/mania; Most studies are conducted in women (Sex-dependent effect); Further evidence is warranted | [160,161,162,163] |
Tyrosine, | Poultry, dairy products, avocado, nuts, pumpkin/sesame seeds | Involved in dopamine and norepinephrine synthesis; Anti-inflammatory effects | Combined use of 100 mg/kg tyrosine plus imipramine show no conclusive antidepressant activity in comparison to placebo; Patients with low levels of dopamine may beneficiate from this nutraceutical | Available data is still controversial | [176,177,178] |
Phenylalanine | Red meats, fish, eggs, dairy products, soy, nuts. | Involved in dopamine and norepinephrine synthesis; Anti-inflammatory effects | Some clinical studies described some favorable effects of phenylalanine in MDD | There are no recent studies conducted in the use of this nutraceutical; it may be related to important adverse effects in patients with Parkinson Disease and pregnant women | [171,172,173,174,175] |
Tryptophan | Soy, fish, poultry, eggs, dairy products, cocoa | Involved in serotonin synthesis | 0.14–3 g of tryptophan per day in a context of a healthy diet may favorably influence patient’s mood | Tryptophan may be converted to quinolinic acid in patients with MDD (Neurotoxicity) | [179,180,181,182,183] |
Vitamin B | Whole grains, meats, eggs, dairy products, seeds, nuts, dark leafy vegetables, fruits | Anti-inflammatory and antioxidant properties | Most trials are negative. However, dual supplementation of probiotics plus vitamin B8 obtained some clinical improvements | Including a varied diet with high vitamin content is much more effective than supplementation according to available scientific data | [198,199,200,201,204] |
Vitamin A | Fruits and vegetables, meats, fish and dairy products | Serum levels of this component are reduced in patients with MDD. | [205,206,207] | ||
Vitamin E | Dark leafy vegetables, nuts, seeds, vegetable oils | Serum levels of this component are reduced in patients with MDD | [205,206,207] | ||
Calcium | Dairy products, fish, dark leafy vegetables | Neuronal gene expression, energy production, membrane excitability, synaptogenesis, synaptic transmission and cognitive functions | One study obtained favorable results from calcium plus vitamin D supplementation, but not alone | This nutraceutical has not provided too much interest | [212,213] |
Magnesium | Dairy products, fish, dark leafy vegetables, legumes, nuts, seeds | Involved in complex cognitive processes | Daily consumption of 500 mg magnesium oxide per day improved depression status and hypomagnesemia; A 6-weeks intervention trial with magnesium in comparison to 6 weeks without any supplement in patients with mild and moderate MDD, regardless of age, gender, baseline severity of depression, baseline magnesium level, or use of antidepressant treatments; Magnesium exerts rapid actions (1–2 weeks) |
Little evidence available | [216,217,218] |
Zinc | Dairy products, fish, dark leafy vegetables, legumes, nuts, seeds, fish, red meat, poultry. | Pleiotropic effects | Zinc combined with antidepressants maximize clinical outcomes even in non-responsive patients | [220,221] | |
Trace elements (Iron, selenium, manganese) |
Meat, fish, cereals, milk and dairy foods, vegetables and nuts | Targeting oxidative stress, monoaminergic system, systemic and local inflammation, GABAergic system, sleep regulation and neuroprotective effects mediated by BDNF | Iron supplementation might provide prophylactic effects in patients with anemia | Further evidence is warranted | [222,223,224,225,226] |
Ultra-trace elements (Lithium) |
Potato, vegetables, fish and seafood | Involved in complex cognitive processes | Some studies reported positive outcomes from long-term prophylaxis for non-responder patients, as well as in the prevention of suicidal thoughts | Most studies are conducted in patients with bipolar disorder | [227,228,229] |
Alkaloids (Caffeine and theobromine) |
Coffee, cocoa | Pleiotropic effects (Non selective antagonist of adenosine receptors) | Different studies have demonstrated the antidepressant effects of caffeine and probably of theobromine | High doses of both components are associated with increased anxiety, depressive and negative symptoms | [238,239,240,241,242,243,244,245] |
Flavonoids polyphenols | Vegetables and fruits | Improved functioning of the monoaminergic system, GABAergic transmission, BDNF activity and amelioration of the neuroinflammatory response in the brain | No clinical studies have been conducted | [248,249] | |
Nonflavonoids polyphenols | Curcumin (Curcuma), resveratrol (grapes) Hydroxytyrosol (Olive oil) |
Improving BDNF activity, serotoninergic and dopamine transmission, antioxidant and anti-inflammatory properties | Some studies have proven antidepressant benefits from curcumin in Asian patients with MDD | Further evidence is warranted | [250,251,252,253,254,255,256] |
CBD | Only supplements | Influences serotoninergic, glutamatergic and GABAergic transmission, as well as the endocannabinoid system; Targeting of multiple cellular and molecular components, increasing the levels of BDNF, neurogenesis and neuroplasticity | - | There are no clinical studies conducted probably by its social perception | [257,258,259,260,261] |